Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.46 |
| ▸ | CYP4Z1 | Q86W10 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.44 |
| ▸ | CYP4F8 | P98187 | 1/20 | 0.44 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | F13A1 | P00488 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29280307 | 0.93 | PTGS1 (0.55) | PTGS1PTGS2MAPK1CYP4Z1CYP1A2 | |
| SCHEMBL1147642 | 0.85 | PTGS1 (0.48) | PTGS1PTGS2MAPK1LMNAALDH1A1 | |
| SCHEMBL10800016 | 0.84 | MGLL (0.48) | PTGS1PTGS2MAPK1LMNAPMP22 | |
| SCHEMBL27315404 | 0.84 | PTGS1 (0.42) | PTGS1PTGS2MAPK1CYP4Z1CYP1A2 | |
| SCHEMBL15579098 | 0.78 | PTGS1 (0.81) | PTGS1PTGS2MAPK1PRMT1LMNA | |
| SCHEMBL3441080 | 0.77 | CDC25A (0.51) | MAPK1CYP4Z1CYP1A2CYP2C8CYP2B6 | |
| SCHEMBL24939859 | 0.76 | PTGS1 (1.00) | PTGS1PTGS2MAPK1LMNATSHR | |
| SCHEMBL8779453 | 0.76 | PTGS1 (1.00) | PTGS1PTGS2MAPK1LMNATSHR | |
| SCHEMBL3291535 | 0.76 | PTGS1 (1.00) | PTGS1PTGS2MAPK1LMNATSHR | |
| SCHEMBL6934781 | 0.76 | PTGS1 (1.00) | PTGS1PTGS2MAPK1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534324-B1 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | GLYKOS FINLAND OY (FI) | 2019-01-16 | — | — | EP | disclosed |
| US-20180055928-A1 | Tumor specific oligosaccharide epitopes and use thereof | GLYKOS FINLAND OY (FI) | 2018-03-01 | — | — | US | disclosed |
| US-20140234318-A1 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | GLYKOS FINLAND OY (FI) | 2014-08-21 | — | — | US | disclosed |
| US-8697061-B2 | Tumor specific oligosaccharide epitopes and use thereof | GLYKOS FINLAND OY (FI) | 2014-04-15 | — | — | US | disclosed |
| EP-2322209-A2 | Tumor specific oligosaccharide epitopes and use thereof | Glykos Finland Oy (FI) | 2011-05-18 | — | — | EP | disclosed |
| US-20060014672-A1 | Tumor specific oligosaccharide epitopes and use thereof | GLYKOS FINLAND OY (FI) | 2006-01-19 | — | — | US | disclosed |
| EP-0487610-B1 | PROHORMONE CLEAVAGE SITE BLOCKING ANTIBODY | CHIRON CORP (US) | 2000-02-09 | — | — | EP | disclosed |
| US-6020206-A | Homocysteine assay | NEXSTAR PHARMACEUTICALS, INC. (US) | 2000-02-01 | — | — | US | disclosed |
| EP-0491828-B1 | PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF | CHIRON CORP (US) | 1999-06-16 | — | — | EP | disclosed |
| WO-1998059242-A1 | HOMOCYSTEINE ASSAY | NEXSTAR PHARMACEUTICALS, INC. (US) | 1998-12-30 | — | — | WO | disclosed |
| US-4894226-A | SPACERS, CROSSLINKING | CETUS CORPORATION (US) | 1990-01-16 | — | — | US | disclosed |
| WO-1989011547-A1 | METHOD FOR HLA DP TYPING | CETUS CORPORATION (US) | 1989-11-30 | — | — | WO | disclosed |
| WO-1989011548-A1 | IMMOBILIZED SEQUENCE-SPECIFIC PROBES | CETUS CORPORATION (US) | 1989-11-30 | — | — | WO | disclosed |
| CN-1037349-A | Novel multipolymer and with this copolymer-modified hemocuprein | KURARAY CO (JP) | 1989-11-22 | — | — | CN | disclosed |
| WO-1989002932-A1 | A COVALENT OLIGONUCLEOTIDE-HORSERADISH PEROXIDASE CONJUGATE | CETUS CORPORATION (US) | 1989-04-06 | — | — | WO | disclosed |
| WO-1989002931-A1 | OLIGONUCLEOTIDE FUNCTIONALIZING REAGENTS AND METHODS | CETUS CORPORATION (US) | 1989-04-06 | — | — | WO | disclosed |
| US-4798787-A | POLYCLONAL | CETUS CORPORATION (US) | 1989-01-17 | — | — | US | disclosed |
| US-4762706-A | ANTICANCER | CETUS CORPORATION (US) | 1988-08-09 | — | — | US | disclosed |
| EP-0177814-A2 | Peptide antibodies and their use in detecting oncogene products | CETUS CORPORATION (US) | 1986-04-16 | — | — | EP | disclosed |
| EP-0175360-A2 | Peptide antibodies and their use in detecting oncogene products | CETUS CORPORATION (US) | 1986-03-26 | — | — | EP | disclosed |